16-31091334-G-A

Variant summary

Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM1PM2PP5_Moderate

The NM_024006.6(VKORC1):​c.292C>T​(p.Arg98Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000583 in 1,613,336 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000063 ( 0 hom. )

Consequence

VKORC1
NM_024006.6 missense

Scores

4
2
10

Clinical Significance

Likely pathogenic criteria provided, single submitter P:2

Conservation

PhyloP100: 0.653

Publications

27 publications found
Variant links:
Genes affected
VKORC1 (HGNC:23663): (vitamin K epoxide reductase complex subunit 1) This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]
VKORC1 Gene-Disease associations (from GenCC):
  • vitamin K-dependent clotting factors, combined deficiency of, type 2
    Inheritance: Unknown, AR Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
  • vitamin K-dependent clotting factors, combined deficiency of, type 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 6 ACMG points.

PM1
In a mutagenesis_site No effect on enzyme activity. Decreases inhibition by warfarin. (size 0) in uniprot entity VKOR1_HUMAN
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 16-31091334-G-A is Pathogenic according to our data. Variant chr16-31091334-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 2206.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VKORC1NM_024006.6 linkc.292C>T p.Arg98Trp missense_variant Exon 3 of 3 ENST00000394975.3 NP_076869.1 Q9BQB6-1A0A0S2Z6I4
VKORC1NM_001311311.2 linkc.376C>T p.Arg126Trp missense_variant Exon 4 of 4 NP_001298240.1 Q9BQB6
VKORC1NM_206824.3 linkc.182C>T p.Ala61Val missense_variant Exon 2 of 2 NP_996560.1 Q9BQB6-3A0A0S2Z5X7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VKORC1ENST00000394975.3 linkc.292C>T p.Arg98Trp missense_variant Exon 3 of 3 1 NM_024006.6 ENSP00000378426.2 Q9BQB6-1
ENSG00000255439ENST00000529564.1 linkc.283+1978C>T intron_variant Intron 2 of 4 4 ENSP00000431371.1 E9PLN8

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152218
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000725
AC:
18
AN:
248290
AF XY:
0.0000744
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000291
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000134
Gnomad OTH exome
AF:
0.000165
GnomAD4 exome
AF:
0.0000630
AC:
92
AN:
1461118
Hom.:
0
Cov.:
31
AF XY:
0.0000605
AC XY:
44
AN XY:
726788
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33476
American (AMR)
AF:
0.0000224
AC:
1
AN:
44620
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26100
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39680
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86162
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53226
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
0.0000747
AC:
83
AN:
1111722
Other (OTH)
AF:
0.0000663
AC:
4
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152218
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41460
American (AMR)
AF:
0.00
AC:
0
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5200
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68036
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000101
Hom.:
0
Bravo
AF:
0.0000340
ExAC
AF:
0.0000906
AC:
11

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Vitamin K-dependent clotting factors, combined deficiency of, type 2 Pathogenic:1
Feb 05, 2004
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Hereditary combined deficiency of vitamin K-dependent clotting factors Pathogenic:1
Feb 03, 2025
Clinical Genetics Laboratory, Skane University Hospital Lund
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Observed in a homozygous state, at our lab, in a patient with matching phenotype. ACMG criteria used: PS3_Supporting, PM2, PM3, PP1_Strong (PMID: 14765194) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.098
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Pathogenic
0.17
CADD
Benign
20
DANN
Uncertain
1.0
Eigen
Benign
-0.20
Eigen_PC
Benign
-0.35
FATHMM_MKL
Benign
0.081
N
LIST_S2
Benign
0.69
T;T;T;T;T
M_CAP
Pathogenic
0.33
D
MetaRNN
Uncertain
0.51
D;D;D;D;D
MetaSVM
Pathogenic
0.98
D
PhyloP100
0.65
PROVEAN
Benign
-0.25
N;N;N;D;D
REVEL
Benign
0.19
Sift
Pathogenic
0.0
D;D;D;T;T
Sift4G
Benign
0.48
T;D;T;D;D
Polyphen
0.24
.;B;.;.;.
Vest4
0.11
MVP
0.85
ClinPred
0.22
T
GERP RS
1.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.12
Mutation Taster
=29/71
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72547528; hg19: chr16-31102655; COSMIC: COSV54923357; COSMIC: COSV54923357; API